Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Shanghai Chest Hospital
University of Wisconsin, Madison
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
MedSIR
M.D. Anderson Cancer Center
Georgetown University
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital with Nanjing Medical University
Hospices Civils de Lyon
Sun Yat-sen University
Shanghai Proton and Heavy Ion Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sun Yat-sen University
Xiangya Hospital of Central South University
Vanderbilt-Ingram Cancer Center
Washington University School of Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Fudan University
Weill Medical College of Cornell University
Shanghai Pulmonary Hospital, Shanghai, China
Fudan University
Fudan University
Chang Gung Memorial Hospital
Ohio State University Comprehensive Cancer Center
Peking Union Medical College Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Amphia Hospital
Shanghai Zhongshan Hospital
Georgetown University
Scripps Health
Shanghai Zhongshan Hospital
Istituto Clinico Humanitas
Istituto Clinico Humanitas
Yale University
Augusta University
Shanghai Cancer Hospital, China
Shanghai Pulmonary Hospital, Shanghai, China
Indiana University
Sun Yat-sen University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Tongji University
Tang-Du Hospital
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Duke University
Fox Chase Cancer Center
Fudan University
Georgetown University